Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Holders of 5% or more of IRIX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Iridex Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Iridex Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Iridex Corp, newest first.

No Schedule 13D or 13G filings on Iridex Corp are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Iridex Corp shares.

No Form 144 notices for Iridex Corp are on file.